Abstract
Cystic fibrosis, an apparent inborn error of metabolism, is a common disease of children and young adults in countries with predominantly Caucasian populations. It was first described by Fanconi et al. in Switzerland following the recognition of the association of congenital cystic pancreatic fibrosis and bronchiectasis in 1936.(1) In this country, it was Andersen(2) who presented in 1938 the first complete description of the disease and introduced the term “cystic fibrosis of the pancreas.” Although other names for the disease have been proposed in the past decades,(3,4) the shortened form of the original name for the disease, “cystic fibrosis,” has become most common. Several detailed reviews have recently appeared in the literature.(3–6)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fanconi, G., E. Uehlinger, and C. Kanuer. 1936. Das Coeliaksyndrom bei angeborener zystischer Pancreasfibromatose and Bronchiectasien. Wien. Med. Wochenschr. 86: 753–760.
Andersen, D. H. 1938. Cystic fibrosis of the pancreas and its relation to celiac disease. Am. J. Dis. Child. 56: 344–351.
Talamo, R. C., B. J. Rosenstein, and R. W. Berninger. 1983. Cystic fibrosis. In: Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. C. Brown, eds. McGraw-Hill, New York. pp. 1189–1197.
Lobeck, C. C. 1972. Cystic fibrosis. In: Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds. McGraw-Hill, New York. pp. 1605–1626.
Quinton, P. M., J. R. Martinez, and U. Hopfer, eds. 1982. Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. San Francisco Press, San Francisco.
Davis, P. B., and P. A. di Sant’Agnese. 1980. A review: Cystic fibrosis at forty-Quo Vadis? Pediatr. Res. 14: 83–87.
di Sant’Agnese, P. A., R. C. Darling, G. A. Perera, and E. Shea. 1953. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Pediatrics 12: 549–557.
Gibson, L. E., and R. E. Cooke. 1959. A test for concentration of electrolytes in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23: 545–552.
Schwartz, I. L., and J. H. Thaysen. 1956. Excretion of sodium and potassium in human sweat. J. Clin. Invest. 35: 114–123.
Lobeck, C. C., and D. Huebner. 1962. Effect of age, sex, and cystic fibrosis on the sodium and potassium content of human sweat. Pediatrics 30: 172–178.
Schulz, I., K. J. Ullrich, E. Fromter, H. Holzgrere, A. Frick, and J. Hegel. 1965. Micropunktion and elektrische Potentialmessung an Schweissdrusen des Menschen. Pfluegers Arch. 284: 360–372.
Mangos, J. A., and N. R. McSherry. 1967. Sodium transport: Inhibitory factor in sweat of patients with cystic fibrosis. Science 158: 135–136.
Emrich, J. M., E. Stoll, B. Friolet, J. P. Colombo, R. Richterich, and E. Rossi. 1968. Sweat composition in relation to rate of sweating in patients with cystic fibrosis of the pancreas. Pediatr. Res. 2: 464–476.
Schultz, I. J. 1969. Micropuncture studies of the sweat formation in cystic fibrosis patients. J. Clin. Invest. 48: 1470–1477.
Mangos, J. A. 1973. Microperfusion study of the sweat gland abnormality in cystic fibrosis. Tex. Rep. Biol. Med. 31: 651–663.
Mangos, J. A. 1973. Microperfusion study of the sweat gland abnormality in cystic fibrosis. Tex. Rep. Biol. Med. 31: 651–663.
Quinton, P. M. 1983. Chloride impermeability in cystic fibrosis. Nature (London) 301: 421–422.
Spicer, S. S., J. V. Briggman, and D. A. Baron. 1982. Morphological and cytochemical correlates of transport in sweat glands of normal and cystic fibrosis subjects. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 11–34.
Bartman, J., and B. H. Landing. 1966. Morphology of the sweat apparatus in cystic fibrosis. Am. J. Clin. Pathol. 45: 455–461.
Huebner, D., C. C. Lobeck, and N. R. McSherry. 1966. Density and secretory activity of sweat glands in patients with cystic fibrosis and in healthy controls. Pediatrics 38: 613–620.
Kaiser, D., E. Drack, and E. Rossi. 1970. Effect of cystic fibrosis sweat on sodium reabsorption by the normal sweat gland. Lancet 1: 1003–1004.
Hadorn, B., and A. A. Roscher. 1982. Exocrine pancreatic function in cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 182–192.
Crossley, J. R., R. B. Elliott, and P. A. Smith. 1979. Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1: 472–474.
Wilcken, B., R. D. Brown, R. Urwin, and D. A. Brown. 1983. Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infants. J. Pediatr. 102: 383–387.
Figarella, C., J. F. Sauniere, L. Multigner, C. Galabert, M. Amourie, M. Filliat, H. Sarles, and L. P. Chazalette. 1981. Exocrine pancreatic function in cystic fibrosis patients without clinical pancreatic insufficiency with special reference to lactoferrin. Proceedings of the 12th Annual Meeting of the European Working Group for Cystic Fibrosis, Berne.
Martinez, J. R. 1982. Alterations in salivary gland structure and function in cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 125–142.
Gugler, E., J. C. Pallavicini, H. Swerdlow, and P. A. di Sant’Agnese. 1967. Role of calcium in submaxillary saliva of patients with cystic fibrosis. J. Pediatr. 71: 585–592.
Chernick, W. S., and G. J. Barbero. 1967. Reversal of submaxillary salivary alterations in cystic fibrosis by guanethidine. Fourth International Conference on Cystic Fibrosis of the Pancreas. Mod. Probl. Paediatr. 10: 125–132.
Wiesmann, U. N., T. F. Boat, and P. A. di Sant’Agnese. 1972. Flow rates and electrolytes in minor salivary gland saliva in normal subjects and patients with cystic fibrosis. Lancet 2: 510–512.
Mangos, J. A., N. R. McSherry, and P. J. Benke. 1967. A sodium transport inhibitory factor in the saliva of patients with cystic fibrosis of the pancreas. Pediatr. Res. 1: 436–442.
Mangos, J. A., and N. R. McSherry. 1968. Studies on the mechanism of inhibition of sodium transport in cystic fibrosis of the pancreas. Pediatr. Res. 2: 378–384.
Taylor, A., J. W. Mayo, T. F. Boat, and L. W. Matthews. 1974. Standardized assay for the sodium reabsorption inhibitory effect and studies of its salivary gland distribution in patients with cystic fibrosis. Pediatr. Res. 8: 861–865.
Nadel, J. A., B. Davis, and R. J. Phillips. 1979. Control of mucus secretion and ion transport in airways. Am. Rev. Physiol. 41: 369–391.
Sturgess, J. 1982. Morphological characteristics of the bronchial mucosa in cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 254–270.
Oppenheimer, E. 1981. Similarity of the tracheobronchial mucous glands and epithelium in infants with and without cystic fibrosis. Hum. Pathol. 12: 36–52.
Wood, R. E., A. Wanner, J. Hirsch, and P. M. Farrell. 1975. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am. Rev. Respir. Dis. 111: 733–738.
Yeates, D. B., J. M. Sturgess, S. R. Kahn, H. Levison, and N. Aspin. 1976. Mucociliary transport in trachea of patients with cystic fibrosis. Arch. Dis. Child. 51: 28–34.
Wood, R. E., and G. J. Legris. 1982. The role of fluid and electrolyte transport abnormalities in the pulmonary pathophysiology of cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 289–298.
Boucher. R., C. J. Narvarte, C. Cotton, M. T. Stutts, M. R. Knowles, A. L. Finn, and J. T. Gatzy. 1982. Sodium absorption in mammalian airways. In: Fluid and Electrolyte Abnormalities in Exocrine Glands in Cystic Fibrosis. P. M. Quinton, J. R. Martinez, and U. Hopfer, eds. San Francisco Press, San Francisco. pp. 271–287.
Knowles, M. R., J. Gatzy, and R. Boucher. 1981. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305: 1483–1492.
Spock, A., H. M. C. Heich, and H. Cress. 1967. Abnormal serum factor in patients with cystic fibrosis of the pancreas. Pediatr. Res. 1: 173–177.
Bowman, R. H., L. H. Lockhart, and M. L. McCombs. 1969. Oyster ciliary inhibition by cystic fibrosis factor. Science 164: 325–326.
Schmoyer, I. R., and F. A. Baglia. 1974. Cystic fibrosis: Effect of media from cultured fibroblasts on ATPase activity. Biochem. Biophys. Res. Commun. 58: 1066–1070.
Farrell, P. M., G. N. Fox, and S. S. Spicer. 1976. Determination and characterization of ciliary ATPase in the presence of serum from cystic fibrosis patients. Pediatr. Res. 10: 127–133.
Doggett, R. G., and G. M. Harrison. 1973. Cystic fibrosis: In vitro reversal of the ciliostatic character of serum and salivary secretions by heparin. Nature New Biol. 243: 251–253.
Carson, S. D., and B. H. Bowman. 1982. Cystic fibrosis. I. Fractionation of the mucociliary inhibitor from plasma. Pediatr. Res. 16: 13–20.
McNeely, M. C., Y. C. Awasthi, D. R. Barrett, T. Iwasumi, L. Schneider, S. Srivastara, and B. H. Bowman. 1982. Cystic fibrosis. II. The urinary mucociliary inhibitor. Pediatr. Res. 16: 21–29.
Blitzer, M. G., and E. Shapiro. 1982. A purified serum glycopeptide from controls and cystic fibrosis patients. I. Comparison of their mucociliary activity on rabbit tracheal explants. Pediatr. Res. 16: 203–208.
Brown, G. A., A. Oshin, M. C. Goodchild, and C. M. Anderson. 1971. Inhibition of sugar transport by plasma from cystic fibrosis patients. Lancet 2: 639–640.
Morin, C. L., J. F. Desjeuz, and L. Authier. 1973. Effect of saliva and serum from patients with cystic fibrosis on intestinal uptake of amnio acids in rat. Biomedicine 19: 133–138.
Taussig, L. M., and J. D. Gardner. 1972. Effects of saliva and plasma from cystic fibrosis patients on membrane transport. Lancet 1: 1367–1369.
Benke, P. J., M. Erbstoeszer, and H. C. Pitot. 1972. Transport of labelled compounds in control and cystic fibrosis cells in vitro. Lancet 1: 182–184.
Araki, H., M. Field, and H. Shwachman. 1975. A new assay for cystic fibrosis factor: Effects of sera from patients with cystic fibrosis on the in vitro electrical properties of rat jejunum. Pediatr. Res. 9: 932–936.
Shapiro, B. L., S. M. Lee, and W. J. Warwick. 1970. The pentose phosphate pathway in cystic fibrosis erythrocytes. Biochem. Biophys. Res. Commun. 39: 816–819.
Bargman, G. J., J. E. Changus, M. Sukup, A. Vale, and H. Pitot. 1975. Effects of cystic fibrosis saliva on inorganic phosphorous esterification by rat liver mitochondria. Pediatr. Res. 9: 31.
Mangos, J. A., N. R. McSherry, P. J. Benke, and A. Spock. 1969. Studies on the pathogenesis of cystic fibrosis: The isoproterenoltreated rat as an experimental model. In: Proceedings of the Fifth Cystic Fibrosis Conference. D. Lawson, ed. Cystic Fibrosis Trust, London. pp. 25–34.
Sturgess, J., and L. Reid. 1973. The effect of isoprenaline and pilocarpine on (a) bronchial mucus-secreting tissue and (b) pancreas, salivary gland, heart, thymus, liver and spleen. Br. J. Exp. Pathol. 54: 388–402.
Martinez, J. R., E. Adelstein, D. Quissel, and G. J. Barbero. 1975. The chronically reserpinized rat as a possible model for cystic fibrosis. I. Submaxillary gland morphology and ultrastructure. Pediatr. Res. 9: 463–469.
Martinez, J. R., P. C. Adshead, D. Quissell, and G. J. Barbero. 1975. The chronically reserpinized rat as a possible model for cystic fibrosis. II. Composition and cilioinhibitory effects of submaxillary saliva. Pediatr. Res. 9: 470–476.
Pivetta, O. H., and E. L. Green. 1973. Exocrine pancreatic insufficiency: A new recessive mutation in mice. J. Hered. 64: 301–302.
Mangos, J. A., G. J. Bargman, J. R. Martinez, and O. M. Rennert. 1976. Physiology and pharmacology of secretion and cystic fibrosis. In: Cystic Fibrosis: Projections into the Future. J. A. Mangos and R. C. Talamo, eds. Stratton Intercontinental Medical Book Corp., New York. pp. 311–336.
Mangos, J. A., N. R. McSherry, and F. Butcher. 1975. Dispersed parotid acinar cells. I. Morphological and functional characterization. Am. J. Physiol. 229: 553–559.
Mangos, J. A., N. R. McSherry, and T. Barber. 1975. Dispersed parotid acinar cells. II. Characterization of adrenergic receptors. Am. J. Physiol. 229: 560–565.
Mangos, J. A., N. R. McSherry, and T. Barber. 1975. Dispersed rat parotid acinar cells. III. Characterization of cholinergic receptors. Am. J. Physiol. 229: 566–569.
Amsterdam, A., and J. D. Jamieson. 1972. Structural and functional characterization of isolated pancreatic exocrine cells. Proc. Natl. Acad. Sci. USA 69: 3028–3032.
Quissell, D. O., and R. S. Redman. 1979. Functional characteristics of dispersed rat submandibular cells. Proc. Natl. Acad. Sci. USA 76: 2789–2793.
Mangos, J. A. 1979. Morphological and functional characterization of isolated human parotid acinar cells in vitro. J. Dent. Res. 58: 2028–2035.
Mangos, J. A. 1980. Characterization of cholinergic and adrenergic receptors in isolated human parotid acinar cells. J. Dent. Res. 59: 156–163.
Mangos, J. A., and W. H. Donnelly. 1981. Isolated parotid acinar cells from patients with cystic fibrosis: Morphology and composition. J. Dent. Res. 60: 19–25.
Mangos, J. A. 1981. Isolated parotid acinar cells from patients with cystic fibrosis: Functional characterization. J. Dent. Res. 60: 797–804.
Rubin, R. P. 1982. Calcium and Cellular Secretion. Plenum Press, New York.
O’Doherty, J., J. F. Garcia-Diaz, and W. M. Armstrong. 1979. Sodium selective liquid ion-exchanger microelectrodes for intracellular measurements. Science 203: 1349–1351.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Publishing Corporation
About this chapter
Cite this chapter
Mangos, J.A. (1987). Cystic Fibrosis. In: Andreoli, T.E., Hoffman, J.F., Fanestil, D.D., Schultz, S.G. (eds) Clinical Disorders of Membrane Transport Processes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1286-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1286-4_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-42699-5
Online ISBN: 978-1-4684-1286-4
eBook Packages: Springer Book Archive